Some acne treatments may initially worsen the appearance of the skin because they accelerate or alter the underlying biological processes involved in acne formation. Acne develops when excess sebum combines with dead skin cells inside the pore, forming microcomedones that may later become visible as blackheads, whiteheads, or inflamed lesions. Many commonly used treatments, including retinoids and chemical exfoliants, work by increasing skin cell turnover and helping clear these blockages. As this process speeds up, pre-existing microcomedones are brought to the surface more quickly, which can temporarily increase the number of visible breakouts before improvement becomes noticeable.
This early phase is often linked to what is described as skin purging, where the treatment is revealing congestion that was already forming beneath the surface rather than creating entirely new acne. The lesions that appear during this period are typically similar to a person’s usual acne and occur in familiar areas of the face. However, not all initial worsening is due to purging. Some treatments, particularly those that are strong or used too frequently, may irritate the skin barrier. Barrier disruption can lead to increased transepidermal water loss, dryness, and inflammation, which may trigger compensatory oil production and contribute to additional breakouts. Distinguishing between purging and irritation is important, as they have different implications for how a treatment should be managed.
Several contributing factors can influence how the skin responds when starting a new acne treatment. The type and strength of the active ingredient play a central role, with retinoids, alpha hydroxy acids, and beta hydroxy acids more commonly associated with initial worsening due to their effects on cell turnover. Benzoyl peroxide, which targets acne-causing bacteria, may also cause irritation in some individuals, particularly at higher concentrations. Skin type is another important factor, as individuals with sensitive or compromised skin barriers may be more prone to irritation-related breakouts. Environmental conditions such as low humidity or high heat can further affect skin tolerance, while skincare habits, including combining multiple active ingredients too quickly, may increase the likelihood of adverse reactions.
Managing this initial phase often involves a balanced and gradual approach. Introducing active ingredients slowly allows the skin to adapt to increased turnover or antibacterial activity while reducing the risk of excessive irritation. Supporting the skin barrier with gentle cleansers and moisturizers can help maintain hydration and resilience during this period. Consistent use is typically necessary for treatments to move beyond the initial adjustment phase, but it is also important to monitor the skin’s response. If worsening is prolonged, severe, or accompanied by significant discomfort, it may indicate that the treatment is not suitable or that adjustments are needed.
It is important to recognize that acne treatments are designed to influence long-term changes in how the skin functions rather than provide immediate cosmetic improvement. The temporary worsening that can occur reflects the skin’s adjustment to these changes, whether through accelerated clearing of clogged pores or a response to irritation. In many cases, this phase is short-lived and followed by gradual improvement as the underlying causes of acne are more effectively managed.
Overall, the initial worsening of acne during treatment is often a sign that the skin is responding to changes in cell turnover, bacterial activity, or barrier function. Understanding this process can help set realistic expectations and support more consistent, informed use of acne treatments. Individuals with persistent or severe reactions are encouraged to seek guidance from a qualified dermatology professional to ensure that their treatment approach is appropriate and well tolerated.
